Patent · US Active

MAdCAM targeted immunotolerance

US11739146B2 · kind B2 · utility

0Cited by
111References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 20, 2020
Grant dateAug 29, 2023
Priority date—
Expiry dateJun 11, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.